Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- Women aged 18 or older
- Women who have been diagnosed with breast cancer and have not yet started any cancer treatment
- Women who are willing to read and sign a consent form agreeing to take part in the study
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- Women who are currently pregnant or breastfeeding
- People who are already taking part in another clinical trial
- People who are currently receiving radiotherapy, chemotherapy, or are recovering from cancer surgery
- People who need urgent or emergency medical care
- People who have a fever or any other illness that affects the condition of their skin
- People who have a significant medical condition or medical history that, in the opinion of the study doctor, may make participation unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 5522999857370
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
Concordance of the diagnosis of abnormality during the VTM exam in relation to the standard exam (mammography);; Frequency of non-visible vascular identification:; Frequency of identifying non-visible textures; Frequency of thermal discrepancy in nearby pixels in areas suspected of non-visible abnormalities:; Frequency of sample changes detected by VTM
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.